C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/06 (2006.01) A61K 38/08 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2074967
Abstract of the Disclosure A hexapeptide represented by formula (II): A-B-Pro-C-D-E ... (I) where A represents an L- or D- form of arginine or lysine whose N-terminal amino group is alkylated or acylated, B represents an L- or D- form of argine, lysine, or histidine, Pro represents an L- or D- form of proline, C represents an L- or D- form of tyrosine, tryptophan, or phenylalanine, D represents an L- or D- form of valine, isolencine, or leucine, and E represents an L-or D- form of valine, isolencine, or lencine, one of the hydrogen atoms of the amino group of which may be substituted a C1 to C4 alkyl group, and C-terminal car- boxyl group of which is substituted with -COOR*, -CH2OR, or -CONHR wherein R* represents a C1 to C4 alkyl group, and R represents a hydrogen atom or an C1 to C4 alkyl group. The hexapeptide or a pharmaceutically acceptable salt of the hexapeptide is useful as medical agent such as an anti-edematous agent, an anti-shock agent, an anti-thrombus agent, an anti-arteriosclerotic agent, an anti-allergic agent, a hypotensive agent, a would healing agent, and an anti-inflammatory agent.
Aburada Masaki
Amagaya Sakae
Fujiwara Tadami
Nagasawa Michio
Oyama Tsutomu
Ridout & Maybee Llp
Tsumura & Co.
LandOfFree
Hexapeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexapeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexapeptide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1747373